CAS ID: | 198153-51-4 |
Molecular Formula: | |
Molecular Weight: | g/mol |
Monoisotopic Mass: | g/mol |
Class: | Protein based biotech |
Natural Product: | No |
Other Names: | PEGASYS | RO 25-8310/000 | ROFERON-A | PEGINTERFERON ALFA-2A |
Analysis: | N/A |
Trial Record 1
ClinicalTrial ID | NCT01634919 | Disease | Liver fibrosis |
Phase | Status | Unknown | |
First Received | July 6, 2012 | Last Verified | October 11, 2017 |
Sponsor | Seoul National University Boramae Hospital |
Trial Record 2
ClinicalTrial ID | NCT00006164 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | August 9, 2000 | Last Verified | May 11, 2018 |
Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Trial Record 3
ClinicalTrial ID | NCT00442572 | Disease | Liver fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | March 2, 2007 | Last Verified | April 6, 2017 |
Sponsor | Hoffmann-La Roche |
Trial Record 4
ClinicalTrial ID | NCT01006031 | Disease | Liver fibrosis |
Phase | Phase 2,Phase 3 | Status | Completed |
First Received | November 2, 2009 | Last Verified | December 30, 2011 |
Sponsor | Sociedad Andaluza de Enfermedades Infecciosas |
Trial Record 5
ClinicalTrial ID | NCT00304551 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Completed |
First Received | March 20, 2006 | Last Verified | June 3, 2010 |
Sponsor | Chugai Pharmaceutical |
Trial Record 6
ClinicalTrial ID | NCT01888900 | Disease | Liver fibrosis |
Phase | Phase 2 | Status | Completed |
First Received | June 28, 2013 | Last Verified | February 7, 2017 |
Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
PubChem: | 47205819 |
ChEMBL: | CHEMBL1201560 |